Neurology
RSSArticles
-
Abstract & Commentary: Treating VAP: The Importance of Getting Initial Antibiotic Coverage Right
This study was a secondary analysis of data from an earlier randomized clinical trial comparing one antibiotic vs two (meropenem alone or meropenem plus ciprofloxacin) as early empiric therapy for ventilator-associated pneumonia (VAP). -
Physician Protect Thyself (and Your Patients and Coworkers)!
The advisory committee on immunization practices (ACIP) of the CDC has updated their recommendations for immunization of health care providers (HCP) against communicable infectious diseases. -
Clinical Briefs By Louis Kuritzky, MD
Between statin head-to-head trials are uncommon. -
Internal Medicine Alert - Full January 29, 2012 Issue in PDF
-
Early Referral of the Chronic Kidney Disease Patient is Good Practice
A meta-analysis demonstrates that earlier nephrologist referral leads to reduced mortality and hospitalization as well as better preparation and dialysis access placement. -
Daytime Sleepiness as a Stroke and Cardiac Risk Factor
Excessive daytime sleepiness appears to be an important risk factor for stroke. It is unknown whether this is related to obstructive sleep apnea or other mechanisms. -
Clobazam Tablets (ONFI™) CIV
A new benzodiazepine anticonvulsant was recently approved for the treatment of a difficult-to-treat childhood epilepsy (Lennox-Gastaut syndrome [LGS]). Clobazam is manufactured by Catalent Pharma Solutions and marketed as ONFI. -
Emergency Medicine Reports - Full January 1, 2012 Issue in Streaming Audio/Downloadable MP3 Format
-
Trauma Reports Supplement
-
Emergency Medicine Reports - Full January 1, 2012 Issue in PDF